Market Tracker

03/04 5:16pm ET

Repligen Corp (NASDAQ:RGEN)

During the Trading Day
25.11 +0.20 / +0.80%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
25.11 0.00 / 0.00%
 
Volume: 3.0K
No recent news for Repligen Corp.

Today’s Trading

Previous close24.91
Today’s open24.75
Day’s range24.24 - 25.56
Volume293,232
Average volume (3 months)329,142
Market cap$815.1M
Dividend yield--
Data as of 4:00pm ET, 03/04/2015

Growth & Valuation

Earnings growth (last year)+11.11%
Earnings growth (this year)-44.67%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+9.48%
P/E ratio69.8
Price/Sales6.34
Price/Book7.66

Competitors

 Today’s
change
Today’s
% change
FOLDAmicus Therapeutics ...-0.07-0.83%
EPZMEpizyme Inc+0.64+2.74%
INFIInfinity Pharmaceuti...+0.21+1.32%
OMEDOncoMed Pharmaceutic...+0.78+3.00%
Data as of 4:00pm ET, 03/04/2015

Financials

Next reporting dateMarch 5, 2015
EPS forecast (this quarter)$0.04
Annual revenue (last year)$68.2M
Annual profit (last year)$16.1M
Net profit margin23.61%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Treasurer, Director &
CAO
Walter C. Herlihy
Chief Operating Officer &
Director
Tony J. Hunt
Corporate headquarters
Waltham, Massachusetts

Forecasts